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Prognostic Factors of Community-acquired Bactere-
mic Patients with  Severe sepsis: A Prospective, Ob-
servational Study
Background: Characterization of clinical features of bacteremic severe sepsis 
acquired from the community has been inadequate; therefore, our goal in this 
study was to identify prognostic factors associated with outcome in patients with 
community-acquired bacteremic severe  sepsis.
Materials and Methods: Adult patients (≥18 years) with community-acquired severe 
sepsis in whom pathogens were identified from blood cultures were included in the 
study. Data were collected prospectively from 12 teaching hospitals between May, 
2005, and February, 2009. Data included demographic characteristics, co-morbid 
medical conditions, primary infection sites, sepsis severity, mortality, causative micro­
organisms, and the appropriateness of initial empirical antibiotic therapy.
Results: During the study period, 1,152 patients were diagnosed with com munity-
acquired severe sepsis and 422 patients were found to harbor pathogens in their 
blood. Among the 422 patients analyzed, 253 (60.0%) patients went into shock and 
121 patients (28.7%) died during hospitalization. Risk factors, including respiratory 
tract infection (odds ratio [OR], 2.60; 95% confidence interval [CI], 1.11-6.09), number 
of organ dysfunctions (OR, 1.39; 95% CI, 1.13-1.71), and higher APACHE II scores 
(OR, 1.08; 95%  CI, 1.03-1.13) showed an association with poor survival, whereas 
Escherichia coli as a pathogen (OR, 0.31; 95% CI, 0.16-0.64) showed an association 
with lower mortality.
Conclusions: In addition to severity of illness, the primary site of infection and causative 
microorganisms were also identified as important prognostic factors in patients with 
community-acquired bacteremic severe sepsis.
Key Words: Prognostic factors, Severe sepsis, Septic shock, Community-acquired 
infections, Bacteremia
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Introduction
Occurrence of severe sepsis, which accounts for 10­30% 
of intensive care unit (ICU) admissions worldwide, is relatively 
common [1­4]. While severe sepsis is a deadly medical condition, 
previous studies involving large obser vational cohorts have 
reported an overall rate of mortality ranging between 28.6­56.0% [5, 
6]. Many factors can be determinants of poor outcome in patients 
with severe sepsis; we argue that there are too many to apply in 
real clinical situations. Typically, the list includes age, severity 
of a patient’s underlying disease, number of dysfunctional organ 
systems, severity of the illness, hypothermia, thrombocytopenia, 
lactic acidosis, multiple sources of infection, positive blood 
cultures, and type of organism [6, 7].
In most studies of severe sepsis, patients were not stratified 
according to whether the infection was community­acquired vs. 
hospital acquired or bacteremic vs. non­bacteremic. Previous 
studies of bacteremic diseases have focused on individual 
organisms or combined community­ and hospital­acquired 
bacteremia [8, 9]. One study suggested an association of patient 
outcomes in cases of severe community­acquired bacteremic 
sepsis with scores for albumin and Acute Physiology and Chronic 
Health Evaluation II (APACHE II) [10]; however, more data are 
needed in order to validate these earlier findings.
Epidemiological and prognostic factors associated with severe 
community­acquired bacteremic sepsis could differ from those 
of hospital­acquired and/or non­bacteremic cases, and could 
inform treatment recommendations and aid in establishment of 
national health policies. Our aim in this study was to describe the 
clinical and microbiological characteristics of patients with severe 
community­acquired bacteremic sepsis, and to determine which 
of these variables are associated with mortality.
Materials and Methods
1. Study design and patients
A prospective, multicenter, observational study was conducted in 
the medical (n=12) and surgical (n=10) intensive care units (ICUs) 
of 12 university­affiliated teaching hospitals in the Republic of 
Korea from April, 2005 to February, 2009. A prospective analysis 
was conducted using data from adult patients (18 years and older) 
with severe community­acquired bacteremic sepsis who had 
been recently admitted to the ICUs of the participating centers. 
Patient follow­up continued until death or discharge from the 
hospital. Cases involving recurrence or relapse were excluded. 
There was no standardized intervention associated with manage­
ment of sepsis, and physicians followed routine medical practices 
in treatment of their patients.
Prior to initiation of the study, the protocol was reviewed and 
approved by the institutional review board from each participating 
center. 
2. Definitions
In this study, for diagnosis of severe sepsis, we used criteria 
developed by Bernard et al. [11, 12], as well as hepatic dysfunction 
(serum bilirubin >21 µmol/L), gastrointestinal dysfunction (stress 
upper gastrointestinal bleeding), and mental change (Glasgow 
coma scale ≤13). Diagnosis of severe sepsis required evidence 
of infection and at least two systemic inflammatory response 
syndrome conditions and at least one organ system dysfunction. 
Septic shock was diagnosed as sepsis with sustained hypotension 
lasting at least one hour despite adequate fluid resuscitation or 
as sepsis requiring vasopressors for maintenance of adequate 
systolic blood pressure [11]. Severe community­acquired sepsis 
was defined as the presence of severe sepsis upon admission or 
sepsis that developed within 24 hours of admission. According 
to the previously mentioned criteria, cases involving nosocomial 
infection were excluded [13]. Infections that became evident <48 
hours after discharge from the hospital were deemed nosocomial 
[13]. Determination of the primary site of infection was based on 
the organs affected and was classified as one of the following: lower 
respiratory tract, intra­abdominal, genitourinary tract, skin and soft 
tissue, central nervous system, or primary bloodstream infection, 
which was defined as a positive blood culture without focus. 
Isolation of one or more viable microorganisms from blood 
cultures resulted in diagnosis of bacteremia. Isolation of common 
skin­dwelling organisms, such as coagulase­negative Staphylo­
coccus species and Bacillus species, from two or more blood 
cultures from a suspected patient was considered significant. 
The final diagnosis was made by infectious disease specialists.
Initial empirical antibiotic therapy was defined as appropriate 
when antibiotics were started intravenously with optimal dosing 
and intervals within 24 hours after recognition of severe sepsis or 
septic shock, and the infecting microorganism was subsequently 
found to be susceptible in vitro to the antibiotics administered. 
3. Data collection
For the first 24 hours following admission, data for each patient 
were collected using the standardized web­based case report 
form via the website of the Korean Society of Infectious Diseases. 
Data included demographic characteristics, co­morbid medical 
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conditions, as determined by Charlson’s comorbidity index [14], 
factors predisposing to infection, primary site of infection, APACHE 
II scores [15], and diagnosis of severe sepsis, septic shock, and 
organ dysfunction. Sepsis­related Organ Failure Assessment 
(SOFA) scores [16], microorganism isolates, and hospital 
mortality data were also collected at admission.
4. Statistical analyses
The Chi­square test or Fisher’s exact test was used for compari­
son of categorical variables. Continuous variables were ex­
pressed as means±standard deviations, and t­tests were per­
formed for comparison of means. For determination of independent 
factors sociated with mortality, variables that showed a significant 
associa tion with in­hospital mortality in univariate analysis were 
further analyzed using multivariate logistic regression analysis. 
Statistical significance was defined as a two­tailed P value<0.05. 
SPSS version 13.0 (SPSS Inc., Chicago, IL, USA) was used in 
perfor mance of statistical analyses.
Results
1. Patient characteristics
During the study period, data from 1,357 cases were collected 
and 1,152 patients were diagnosed with severe community­
acquired sepsis. Among them, 422 patients documented as 
having severe community­acquired bacteremic sepsis were 
subsequently included in this study (Fig. 1). While occurrence of all­
cause in­hospital mortality was observed in 121 patients (28.7%), 
7­day and 28­day mortality rates were 14.9% (63 of 422) and 
24.6% (104 of 422), respectively. The mean hospital stay was 3.96
±93.08 days (range 0­939, median 16 days).
Sex distribution was nearly equal, and the mean age (years) 
of patients was 64.6±14.3 (range 18­97, median 66). Underlying 
disease was observed in 300 patients (71.1%), with a mean 
Charlson score index of 1.6±1.3 (range 0­9). Detailed co­
morbidity and severity parameters for the enrolled patients are 
shown in Table 1. Initially detected major clinical manifestations 
were as follows: hypotension (58.3 %), hematologic dysfunction 
(58.3%), renal dysfunction (41.2%), liver dysfunction (37.4 
%), mental change (36.0%), respiratory failure (32.5%), me­
tabolic acidosis (29.6%), cardiac dysfunction (13.5%), and 
gastrointestinal bleeding (3.3%). The mean number of organ 
dysfunctions was 2.7±1.6 (range, 0­7). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1,357 enrolled cases 
1,284 community-acquired cases 
1,191 confirmed cases of severe sepsis or septic shock 
1,152 confirmed cases of severe sepsis or septic shock from bacterial infection 
Level 1 exclusion: (n=73) 
Hospital acquired sepsis 
Level 2 exclusion: (n=93) 
No meet severe sepsis or septic shock 
Level 3 exclusion: (n=39) 
Sepsis due to fungus, tuberculosis and atypical organism  
422 - Finally included cases 
Level 4 exclusion: (n=730) 
Blood culture negative 
Figure 1. Process used for selection of eligible patients with bacteremia from 
among those with severe community-acquired sepsis.
Table 1. Demographic and Clinical Characteristics and Mortality in Community-
acquired Bacteremic Patients with Severe Sepsis
Characteristics Total
Survivors 
(%) 
(n=301)
Non-survivors
(%) 
(n=121)
P-
valuea
Male gender, n (%) 223 (52.8)   163 (54.2) 60 (49.6) 0.395
Age, mean±SD, year 64.6±14.3 64.7±14.2 64.4±14.5 0.832
Co-morbidities, n (%)
Cardiovascular disorders 160 (37.9) 114 (37.9) 46 (38.0) 0.978
Central nervous system disorders 64 (15.2) 50 (16.6) 14 (11.6) 0.192
Cancer 57 (13.5) 39 (13.0) 18 (14.9) 0.602
Trauma 6 (  1.4) 5 (  1.7) 1 (  0.8) 0.678b
Renal diseases 20 (  4.7) 16 (  5.3) 4 (  3.3) 0.380
Liver diseases 34 (  8.1) 28 (  9.3) 6 (  5.0) 0.138
Lung diseases 31 (  7.3) 23 (  7.6) 8 (  6.6) 0.714
Organ transplant 5 (  1.2) 3 (  1.0) 2 (  1.7) 0.628b
Connective tissue diseases 8 (  1.9) 7 (  2.3) 1 (  0.8) 0.449b
Metabolic diseases 120 (28.4) 89(29.6) 31 (25.6) 0.416
Hematological disorders 13 (  3.1) 10 (  3.3) 3 (  2.5) 0.765b
Others 9 (  2.0) 6 (  2.0) 3 (  1.7) 1.000b
Any underlying comorbidities, n (%) 300 (71.1) 219 (72.8) 81 (66.9) 0.233
Charlson’s index score, mean±SD 1.6±1.3 1.3±0.1 1.2±0.2 0.761
Severity parameters
APACHE II score, mean±SD 19.4±7.0 17.1±5.7 23.1±8.2 <0.001
SOFA score (day 1), mean±SD 7.2±3.8 7.3±3.8 6.8±3.8 0.208
SOFA score (day 2), mean±SD 6.5±4.3 6.6±4.4 6.3±4.1 0.580
SOFA score (day 3), mean±SD 6.1±4.5 6.2±4.7 5.7±4.9 0.318
SOFA score (day 4), mean±SD 5.7±4.8 5.8±4.8 5.5±4.8 0.629
SOFA score (day 5), mean±SD 5.2±4.8 5.2±4.8 5.0±4.8 0.759
Number of organ failures, n (%) 2.7±1.6 2.3±1.5 3.5±1.6 <0.001
Septic shock, n (%)  253 (60.0) 185 (61.5)    68 (56.2) 0.318
Inadequate empirical 
antimicrobial treatment, n (%)
   32 (  7.6)     9 (  7.4)    23 (   7.6) 0.878
Red blood cell transfusion, n (%) 144 (34.1) 81 (26.9)   63 (52.1) <0.001
APACHE II, Acute Physiology and Chronic Health Evaluation II score; SOFA, Sepsis-related 
Organ Failure Assessment; SD, standard deviation
aP-values were obtained by using the Chi-square test, unless otherwise indicated.
bFisher’s exact test was used.
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2. Primary site of infection
The most common primary site of infection was intra­abdominal 
(34.4%), followed by the urinary tract (28.4%), primary bloodstream 
(11.1%), and respiratory tract (10.9%). In­hospital mortality due to 
respiratory tract, primary bloodstream, skin and soft tissue, intra­ 
abdominal, cardiovascular, and urinary tract infections was 54.3 
%, 46.8%, 39.4%, 29.0%, 13.3%, and 9.2%, respectively (Table 2). 
3. Microbiology 
Compared with Gram­positive bacteria (25.1%), a greater per­
centage of pathogens were Gram­negative bacteria (72.0%). 
Polymicrobial infections and anaerobic infections accounted for 
2.8% and 0.2% of infections, respectively. Among Gram­negative 
microorganisms, the most common pathogen was Escherichia 
coli (37.7%), followed by Klebsiella pneumoniae (22.0%). The most 
common Gram­positive pathogen was Staphylococcus aureus 
(11.8%), followed by Streptococcus pneumoniae (10.2%). The top 
three common causative microorganisms according to primary 
site of infection are shown in Table 3. 
4. Independent risk factors for in-hospital mortality
In univariate analysis of the demographic and clinical charac­
teristics of patients and their severity of illness, the APACHE II 
score and the number of organ dysfunctions differed significantly 
between survivors and non­survivors (Table 1). Only a small 
proportion of patients (32/422, 7.6%) re ceived inappropriate 
antibiotic treatment; therefore, inadequate initial antimicrobial 
treatment might not contribute to in­hospital mortality. Mortality 
rate is higher for patients with sepsis associated with respiratory 
tract infection, primary bloodstream infection, or caused by 
Pseudomonas aeruginosa or S. aureus, while a lower mortality 
rate was observed for patients with urinary tract infections and  E. 
coli as a pathogen (Tables 2 and 4).
Multivariate logistic regression analysis was performed for 
further analysis of significant parameters found by univariate 
analyses. Respiratory tract infection (odds ratio [OR], 2.60; 95% 
confidence interval [CI], 1.11­6.09), number of organ system dys­
functions (OR, 1.39; 95% CI, 1.13­1.71), and APACHE II score (OR, 
1.08; 95% CI, 1.03­1.13) showed an association with a greater 
Table 2. Primary Site of Infection and Mortality in Community-acquired Bac-
teremic Patients with Severe Sepsis
Total
Survivors 
(%) 
(n=301)
Non-survivors 
(%) 
(n = 121)
P-
valuea
Abdomenb 145 (34.4) 103 (34.2) 42 (34.7) 0.923
Urinary tract 120 (28.4) 109 (36.2) 11 (   9.1) <0.001
Primary bloodstream 47 (11.1) 25 (  8.3) 22 (18.2) 0.004
Respiratory system 46 (10.9) 21 (  7.0) 25 (20.7) <0.001
Skin and soft tissue 33 (  7.8) 20 (  6.6) 13 (10.7) 0.156
Cardiovascular system 15 (  3.6) 13 (  4.3) 2 (  1.7) 0.250C
Bone and joint 7 (  1.7) 5(  1.7) 2 (  1.7) 1.000C
Central nervous system 5 (  1.2) 3 (  1.0) 2 (  1.7) 0.628C
Head and neck 3 (  0.7) 1 (  0.3) 2 (  1.7) 0.199C
Reproductive tract 1 (  0.2) 1 (  0.3) 0 1.000
aP-values were obtained using the Chi-square test, unless otherwise indicated.
bAbdominal infections include gastrointestinal tract infection (n=42), liver abscess (n=37), 
and other intra-abdominal infection (n=66). 
CFisher’s exact test was used.
Table 3. The three most Common Microorganisms According to Primary Sites of 
Infection and Mortality in Community-acquired Bacteremic Patients with Severe 
Sepsis
Total
Survivors 
(%)
Non-survivors 
(%)
P-
valuea
Abdomen 145 103 42
Klebsiella pneumoniae 56 (38.6) 41 (39.8) 15 (35.7) 0.646
Escherichia coli 53 (36.6) 41 (39.8) 12 (28.6) 0.203
Streptococcus pneumoniae 6 (  4.1) 5 (  4.9) 1 (  2.4) 0.673b
Urinary tract 120 109 11
Escherichia coli 90 (75.0) 83 (76.1) 7 (63.6) 0.464b
Klebsiella pneumoniae 11 (  9.2) 10 (  9.2) 1 (  9.1) 1.000b
Proteus mirabilis 7 (  5.8) 7 (  6.4) 0 1.000b
Primary bloodstream  47 25 22
Staphylococcus aureus 11 (23.4) 3 (12.0) 8 (36.4) 0.049
Klebsiella pneumoniae 9 (19.1) 6 (24.0) 3 (13.6) 0.470b
Escherichia coli 6 (12.8) 4 (16.9) 2 (  9.1) 0.670b
Respiratory system 46 21 25
Klebsiella pneumoniae 14 (30.4) 5 (23.8) 9 (36.0) 0.371
Streptococcus pneumoniae 13 (28.3) 7 (33.3) 6 (24.0) 0.484
Staphylococcus aureus 8 (17.4) 4 (19.0) 4 (16.0) 0.786b
aP-values were obtained using the Chi-square test, unless otherwise indicated.
bFisher’s exact test was used.
Table 4. Causative Microorganisms and Mortality in Community-acquired 
Bacteremic Patients with Severe Sepsis
Total
Survivors 
(%) 
(n=301)
Non-survivors
(%) 
(n=121)
P-  
valuea
Microorganisms, n (%)
  Escherichia coli 159 (37.7) 137 (45.5) 22 (18.2) <0.001
  Klebsiella pneumoniae 93 (22.0) 63 (20.9) 30 (24.8) 0.387
  Streptococcus pneumoniae 43 (10.2) 31 (10.3) 12 (  9.9) 0.907
  Staphylococcus aureus 50 (11.8) 25 (  8.3) 25 (20.7) 0.001
  Pseudomonas aeruginosa 13 (  3.1) 5 (  1.7) 8 (  6.6) 0.012b
  Enterococcus spp. 8 (  1.9) 7 (  2.3) 1 (  0.8) 0.449b
  Enterobacter cloacae 9 (  2.1) 5 (  1.7) 4 (  3.3) 0.285b
  Proteus mirabilis 10 (  2.4) 7 (  2.3) 3 (  2.5) 1.000b
  Haemophilus influenzae 3 (  0.7) 2 (  0.7) 1 (  0.8) 1.000b
  Citrobacter freundii 4 (  0.9) 1 (  0.3) 3 (  2.5) 0.073b
  Coagulase negative staphylococcus 5 (  1.2) 4 (  1.3) 1 (  0.8) 1.000b
  Bacteroides fragilis 4 (  0.9) 2 (  0.7) 2 (  1.7) 0.325b
  Others 21 (  5.0) 12 (  4.0) 9 (  7.4) 0.140
aP-values were obtained using the Chi-square test, unless otherwise indicated.
bFisher’s exact test was used.
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risk of death, whereas E. coli bacteremia (OR, 0.31; 95% CI, 0.16­
0.64) was associated with a lower risk. Independent risk factors 
associated with 7­day and 28­day mortality in multivariate 
logistic regression analysis are shown in Table 5.
Discussion
In the present study, all­cause in­hospital mortality was 28.7% 
(121 of 422 patients). Patients who presented with shock showed 
a slightly lower rate of mortality (26.9%) than patients without 
shock. As reported in previous studies, mortality resulting from 
severe sepsis ranged from 28.6­56.0%, and mortality rate for 
patients with septic shock were higher (40­70%) than those of 
patients with sepsis alone (25­30%) [3, 5, 6, 17, 18]. In a study of 
patients with severe community­acquired bacteremic sepsis, 
Artero et al. reported an all­cause in­hospital mortality rate of 
34.4% [10], higher than the mortality rate recorded in this study. 
The modest result for general mortality and the unexpected 
result for lower mortality in patients with shock may be due to 
inclusion of cases with different disease severities, as reflected 
by APACHE II scores, compared to the previous study (19.4 in our 
study vs. 22.0 in the other study), as well as a disparity in the most 
common site of primary infection (urinary tract infection in our 
study vs. respiratory tract infection in the previous study) [10]. 
Our finding that E. coli was the most common isolate from 
patients with severe community­acquired bacteremic sepsis 
(159 of 422, 37.7%) is in agreement with results reported by 
Diekema et al. [19]. However, other studies have reported a 
general, worldwide increase in occurrence of Gram­positive 
infections, such as S. aureus infections [10, 20, 21]. Differences 
in proportions of causative organisms may be the result of 
differences in the primary focus of infection. Mylotte et al. [20] 
reported pneu monia as the most common site of infection. 
However, in our study, the most common primary site of infection 
was intra­abdo minal (34.4%), followed by the urinary tract 
(28.4%), pri mary bloodstream (11.1%), and respiratory tract 
(10.9%). Consistent with the findings of other studies, we found 
that lower respiratory tract infection, severity of illness upon 
admission, and the presence of multiple organ dysfunctions were 
the major factors associated with a poor prognosis in Korean 
patients with severe community­acquired bacteremic sepsis 
[8, 10, 20, 22, 23]. Infection with E. coli showed an association with 
lower mortality, which is also consistent with results reported by 
another study [24]. No significant association was observed bet­
ween inadequate empirical antimicrobial treatment and higher 
mortality. However, administration of inadequate empirical 
antimicrobial treatment to critically ill patients with blood stream 
infections has been reported as a key prognostic factor leading to a 
poor outcome [25, 26]. Discordance between results of our study 
and those of previous studies might be attributed to the fact that, 
in our study, only a few patients (7.6%) received inappropriate 
initial antibiotic treatment. The low rate of inadequate antimicrobial 
treatment may be due to the nature of the involved hospitals; all 
patients were recruited from university­affiliated teaching hospitals 
with specialists in infectious disease on staff. 
This study had several limitations. First, it was performed within 
the ICUs of 12 university­affiliated teaching hospitals having a low 
prevalence of inadequate antimicrobial treatment. Therefore, 
it may be that the results of this study cannot be generalized to 
other hospitals. Second, it was an observational study, and, even 
though there was no standardized intervention for management 
of sepsis at different hospitals, the study center was not included 
as a separate variable. Nevertheless, specialists in infectious 
disease, especially those trained to care for critically ill patients, 
participated in management of these patients. Third, our patient 
Table 5. Risk Factors Associated with Mortality Based on Multivariate Logistic Regression Analysis of the Characteristics of Community-acquired Bacteremic Patients 
with Severe Sepsis
Variable
In-hospital mortalitya 7-day mortalityb 28-day mortalityC
OR 95% CI OR 95% CI OR 95% CI
E. coli  bacteremia 0.314 0.16-0.64 0.34   0.14-0.81 0.36 0.18-0.74
Respiratory tract infection 2.60 1.11-6.09 3.51 1.458-8.46 2.89 1.24-6.76
No. of organ system dysfunctions
 (per 1-organ system increment)
1.39 1.13-1.71 1.44   1.14-1.80 1.47 1.19-1.82
APACHE II score (per 1-point increment) 1.08 1.03-1.13 1.08   1.03-1.13 1.06 1.02-1.111
OR, odds ratio; CI, confidence interval; APACHE II, Acute Physiology and Chronic Health Evaluation II score
aIn multivariate logistic regression analysis, age, sex, number of organ system dysfunctions, APACHE II score, primary bloodstream infection, respiratory tract infection, Pseudomonas 
aeruginosa bacteremia, Escherichia coli bacteremia, Staphylococcus aureus bacteremia, and red blood cell transfusion were included.
bIn multivariate logistic regression analysis, age, sex, number of organ system dysfunctions, APACHE II score, primary bloodstream infection, respiratory tract infection, and E. coli bacteremia 
were included.
cIn multivariate logistic regression analysis, age, sex, number of organ system dysfunctions, APACHE II score, primary bloodstream infection, respiratory tract infection, E. coli  bacteremia, and 
red blood cell transfusion were included. 
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cohort did not include a consecutive series of ICU patients with 
community­acquired infections, which may have led to selection 
bias for more severe infections, with a higher likelihood of mor­
tality. However, there is no reason to believe that this would have 
changed the predisposing factors associated with mortality.
In conclusion, we found that disease severity, based on 
both the number of organ system dysfunctions and APACHE II 
score, in addition to microbiological factors and primary site of 
bacteremia, are in­hospital prognostic determinants of outcome in 
patients with severe community­acquired bacteremic sepsis in 
Korea.
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